PET and Clinical Changes in Diagnosis
A prospective cohort study of patients offered amyloid PET as part of their dementia work-up. The results here.
Published in
The conclusion…amyloid positive and amyloid negative findings were associated with changes in diagnosis and treatment protocols.
The authors noted this study bridges the research use and validates the findings of using amyloid PET as a clinical tool in daily clinical practice.
Source: de Wild A, van der Flier WM, Pelmkmans W, et al.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
- Setting Realistic Expectations for Antiamyloid Therapeutics
September 11th 2025